US Broker Ratings

SpringWorks Therapeutics, Inc. (SWTX) Stock Analysis: Biotechnology Innovator with Rapid Revenue Growth

SpringWorks Therapeutics, Inc. (NASDAQ: SWTX) stands out in the biotechnology sector as a company that is not only making significant strides in addressing rare diseases and cancers but also posting..

Twist Bioscience Corporation (TWST) Stock Analysis: Navigating a 28% Potential Upside Amidst Growth in Synthetic DNA

Twist Bioscience Corporation (NASDAQ: TWST) is making waves in the healthcare sector, specifically within the diagnostics and research industry. Specializing in the manufacture and sale of synthetic DNA-based products, Twist..

Biohaven Ltd. (BHVN) Stock Report: Analyzing a 282% Potential Upside in the Biotechnology Sector

For investors seeking opportunities in the healthcare sector, Biohaven Ltd. (BHVN) presents an intriguing proposition with its focus on pioneering therapies in immunology, neuroscience, and oncology. Despite a challenging market..

ImmunityBio, Inc. (IBRX): Exploring a Biotechnology Powerhouse with a 293% Potential Upside

ImmunityBio, Inc. (NASDAQ: IBRX) stands out in the biotechnology sector with its innovative approach to developing therapies that enhance the body’s natural immune response to combat cancers and infectious diseases...

IDEAYA Biosciences, Inc. (IDYA) Stock Analysis: 126% Potential Upside Captivates Investors

IDEAYA Biosciences, Inc. (NASDAQ: IDYA) is capturing the attention of investors with its promising potential upside of 126.20%. As a cutting-edge player in the healthcare sector, specifically in biotechnology, IDEAYA..

Kiniksa Pharmaceuticals, Ltd. (KNSA) Stock Analysis: Exploring a 31.94% Upside Potential in the Biopharmaceutical Space

Kiniksa Pharmaceuticals, Ltd. (NASDAQ: KNSA) is generating significant interest among investors, thanks to its promising pipeline of novel therapies and the potential for substantial upside. As a key player in..

Kymera Therapeutics, Inc. (KYMR) Stock Analysis: Biotech Pioneer with 35.86% Potential Upside

Kymera Therapeutics, Inc. (NASDAQ: KYMR) is making waves in the biotechnology sector, renowned for its innovative approach to drug development. With a focus on harnessing the body’s natural protein degradation..

Arrowhead Pharmaceuticals (ARWR) Stock Analysis: Unpacking a 136% Potential Upside

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR), a dynamic player in the biotechnology industry, has been making waves with its innovative approach to developing treatments for intractable diseases. With a market capitalization..

Astrana Health Inc. (ASTH) Stock Analysis: A Healthcare Player with a Potential 90% Upside

Astrana Health Inc. (ASTH), a prominent player in the healthcare sector, is turning heads with a forecasted potential upside of 90.64%. As a healthcare management company, Astrana provides an array..

Harmony Biosciences Holdings, Inc. (HRMY): Analyst Consensus Points to a 48.53% Potential Upside

Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY), a leading figure in the biotechnology sector, has been making waves with its innovative approach to treating rare and neurological diseases. With a market..

Apogee Therapeutics (APGE) Investor Outlook: 141% Potential Upside Sparks Interest in Biotech Stock

Apogee Therapeutics, Inc. (APGE) is capturing the attention of investors with its dynamic potential upside of 141.45%, highlighting significant opportunities within the high-stakes biotechnology sector. As a clinical-stage biotech firm..

Alignment Healthcare, Inc. (ALHC) Stock Analysis: Exploring a 35.99% Potential Upside in the Healthcare Sector

Alignment Healthcare, Inc. (NASDAQ: ALHC) stands out in the competitive healthcare plans sector, offering a promising investment opportunity with a potential upside of 35.99%. Based in Orange, California, the company..

Phreesia, Inc. (PHR) Stock Analysis: Exploring a 14.65% Potential Upside Amid Strong Revenue Growth

Phreesia, Inc. (NYSE: PHR) is gaining traction among investors, particularly those keen on the healthcare sector’s digital transformation. With a market capitalization of $1.64 billion, the company plays a pivotal..

Tandem Diabetes Care, Inc. (TNDM) Stock Analysis: Assessing a 107% Potential Upside in the Healthcare Sector

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a key player in the medical devices industry, is capturing investor attention with its significant potential upside. With an average target price suggesting a..

Amedisys Inc (AMED) Stock Analysis: Navigating the Healthcare Sector with a Forward P/E of 19.07

Amedisys Inc (NASDAQ: AMED), a key player in the healthcare sector, is garnering attention from investors seeking opportunities in the medical care facilities industry. Headquartered in Baton Rouge, Louisiana, Amedisys..

Xenon Pharmaceuticals Inc. (XENE) Stock Analysis: A Promising 69% Upside Potential in the Biotech Arena

Xenon Pharmaceuticals Inc. (NASDAQ: XENE), a pioneering force in the biotechnology sector, is captivating investor attention with its robust pipeline of neurological and psychiatric therapeutics. With a market capitalization of..

Evotec SE (EVO) Stock Analysis: A Glimpse into Its 47.51% Potential Upside

Evotec SE (NASDAQ: EVO) is a prominent player in the healthcare sector, specializing in drug discovery and development. With a market capitalization of $1.47 billion, this German-based company is a..

Liquidia Corporation (LQDA) Investor Outlook: Analyzing a 109% Upside Potential in the Biotech Space

Liquidia Corporation (NASDAQ: LQDA), a promising player in the biotechnology sector, is garnering significant attention from investors due to its potential upside of 109.25%. Based in Morrisville, North Carolina, Liquidia..

Belite Bio, Inc (BLTE) Stock Analysis: Exploring a Potential 33.69% Upside in the Biotech Sector

Belite Bio, Inc (NASDAQ: BLTE) is making waves in the biotechnology sector, capturing the attention of investors with its innovative approach to tackling retinal degenerative diseases. Headquartered in San Diego,..

Perrigo Company plc (PRGO) Stock Report: Exploring a Potential 33% Upside in Healthcare

For investors with a keen interest in the healthcare sector, Perrigo Company plc (NYSE: PRGO) presents a compelling opportunity. Based in Dublin, Ireland, Perrigo operates as a powerhouse in the..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds